Voegel A

Analysis Group, Inc., 1190 avenue des Canadiens-de-Montréal, Suite 1500, Montréal, QC, H3B 0G7, Canada.

3 papers

ArticleKetamine

Profiles of Medicaid Beneficiaries with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray.

Clemens K, Zhdanava M, Teeple A +6

Europe PMC2025
ArticleKetamine

Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA.

Jha MK, Zhdanava M, Shah A +4

Europe PMC2025
ArticleKetamine

Impact of social determinants of health on esketamine nasal spray initiation among patients with treatment-resistant depression in the United States.

Clemens K, Zhdanava M, Teeple A +5

Europe PMC2025